Position in MRNA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$322,698
+$99,788 QoQ
Shares Held
4,608
+5.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#429
of 772 holders
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Crestwood Advisors Group, LLC holds $9,188,630 across 10 Biotechnology names. MRNA ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,184 | $3,568,508 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
100,274 | $3,348,148 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
743 | $463,290 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,561 | $376,154 | |
| 5 | INCY |
Incyte Corp
|
3,265 | $370,120 | |
| 6 | MRNA |
Moderna, Inc.
This page
|
4,608 | $322,698 | |
| 7 | CCCC |
C4 Therapeutics, Inc.
|
66,536 | $310,722 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
34,410 | $301,259 |
All Filings in MRNA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322,698 | 4,608 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $222,910 | 4,388 | Shares | Sole | 2026-05-05 | |
| 2021-12-31 | $384,271 | 1,513 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $559,586 | 1,454 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $305,474 | 1,300 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||